Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06365216
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-05
First Post:
2024-04-09
Brief Title:
ALS Phase II Study of NX210c
Sponsor:
Axoltis Pharma
Organization:
Axoltis Pharma
Organization Data
Organization:
Axoltis Pharma
Class:
INDUSTRY
Study ID:
AXO-CLI-210c-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Axoltis Pharma
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| ACT4ALS network | UNKNOWN |